Thrombosis risk prediction in lymphoma patients: A multi‐institutional, retrospective model development and validation study
Sign Up to like & getrecommendations! Published in 2024 at "American Journal of Hematology"
DOI: 10.1002/ajh.27335
Abstract: Venous thromboembolism (VTE) poses a significant risk to cancer patients receiving systemic therapy. The generalizability of pan‐cancer models to lymphomas is limited. Currently, there are no reliable risk prediction models for thrombosis in patients with… read more here.
Keywords: lymphoma patients; history; risk; model ... See more keywords
Factors of emotional distress in lymphoma: A systematic review.
Sign Up to like & getrecommendations! Published in 2023 at "Cancer medicine"
DOI: 10.1002/cam4.6069
Abstract: OBJECTIVE Distress is prevalent among lymphoma patients/survivors. Current processes of distress identification rely on self-reporting by patients/survivors, which may be limited by their willingness to report symptoms. To help identify patients/survivors at greater risk, this… read more here.
Keywords: distress; patients survivors; systematic review; distress lymphoma ... See more keywords
OUTCOMES OF PATIENTS WITH LYMPHOMA AND COVID‐19: AN OBSERVATIONAL COHORT STUDY FROM GELTAMO SPANISH GROUP
Sign Up to like & getrecommendations! Published in 2021 at "Hematological Oncology"
DOI: 10.1002/hon.200_2880
Abstract: Introduction: COVID-19 is thought to be more frequent and severe in patients with cancer. Lymphoma patients may be especially vulnerable, due to the immunodeficiency and immune dysregulation caused by the lymphoma itself and the antitumor… read more here.
Keywords: lymphoma; patients lymphoma; treatment; study ... See more keywords
COMPARATIVE ANALYSIS OF PREDICTIVE MODELS FOR THROMBOEMBOLIC EVENTS IN LYMPHOMA PATIENTS
Sign Up to like & getrecommendations! Published in 2017 at "Hematological Oncology"
DOI: 10.1002/hon.2439_198
Abstract: ing the side effect profile. Methods: Data from 2012 to 2016 were collected retrospectively from pharmacy records for all lymphoma patients treated with thalidomide. The majority of these patients were multiply relapsed. Patients were all… read more here.
Keywords: comparative analysis; patients treated; models thromboembolic; lymphoma patients ... See more keywords
Long telomeres at baseline and male sex are main determinants of telomere loss following chemotherapy exposure in lymphoma patients.
Sign Up to like & getrecommendations! Published in 2022 at "Hematological oncology"
DOI: 10.1002/hon.3118
Abstract: Although chemotherapy (CHT) exposure is an established cause of telomere attrition, determinants of telomere length (TL) dynamics after chemotherapy are poorly defined. In this study, we analyzed granulocyte telomere dynamics in 34 adult lymphoma patients… read more here.
Keywords: exposure; telomere loss; cht; chemotherapy ... See more keywords
Lower socioeconomic status is independently associated with shorter survival in Hodgkin Lymphoma patients—An analysis from the Brazilian Hodgkin Lymphoma Registry
Sign Up to like & getrecommendations! Published in 2018 at "International Journal of Cancer"
DOI: 10.1002/ijc.31096
Abstract: Socioeconomic status (SES) is a well‐known determinant of outcomes in cancer. The purpose of this study was to analyze the impact of the SES on the outcomes of Hodgkin lymphoma (HL) patients from the Brazilian… read more here.
Keywords: lymphoma; lower ses; hodgkin lymphoma; lymphoma patients ... See more keywords
A Comparison of Two Different Scales in Identifying the Risk of Falls in Leukaemia and Lymphoma Patients
Sign Up to like & getrecommendations! Published in 2025 at "Nursing Open"
DOI: 10.1002/nop2.70221
Abstract: This study was conducted to assess the risk of falls in leukaemia and lymphoma patients using the Itaki Fall Risk Scale and the Fall Risk Assessment Scale Developed by the Delmarva Foundation and compare the… read more here.
Keywords: lymphoma patients; leukaemia lymphoma; falls leukaemia; risk ... See more keywords
Prognostic role of regulatory T cells in lymphoma: a systematic review and meta-analysis
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Cancer Research and Clinical Oncology"
DOI: 10.1007/s00432-020-03398-1
Abstract: The regulatory T cells (Tregs) are a subpopulation of lymphocytes that suppress the immune responses. The prognostic value of Tregs in lymphoma patients remains controversial. Thus, we conducted this meta-analysis to clarify the role of… read more here.
Keywords: lymphoma; analysis; regulatory cells; lymphoma patients ... See more keywords
Effects of live music during chemotherapy in lymphoma patients: a randomized, controlled, multi-center trial
Sign Up to like & getrecommendations! Published in 2019 at "Supportive Care in Cancer"
DOI: 10.1007/s00520-019-04666-8
Abstract: PurposeChemotherapy is associated with both somatic and psychological side effects. Music might ease these problems. Several randomized controlled trials have investigated the effect of music, but the results are inconclusive. We aimed to examine whether… read more here.
Keywords: chemotherapy; randomized controlled; anxiety; lymphoma patients ... See more keywords
Venous thromboembolic events in lymphoma patients: Actual relationships between epidemiology, mechanisms, clinical profile and treatment.
Sign Up to like & getrecommendations! Published in 2018 at "Blood reviews"
DOI: 10.1016/j.blre.2017.10.002
Abstract: Venous thromboembolic events (VTE) are an underestimated health problem in patients with lymphoma. Many factors contribute to the pathogenesis of thromboembolism and the interplay between various mechanisms that provoke VTE is still poorly understood. The… read more here.
Keywords: thromboembolic events; vte; risk; lymphoma patients ... See more keywords
Acute decompensated heart failure as a reason of premature chemotherapy discontinuation may be independent of a lifetime doxorubicin dose in lymphoma patients with cardiovascular disorders.
Sign Up to like & getrecommendations! Published in 2017 at "International journal of cardiology"
DOI: 10.1016/j.ijcard.2017.02.073
Abstract: BACKGROUND Algorithm of anthracycline-based chemotherapy with favourable cardio-oncological outcome should be clearly re-defined for lymphoma patients with significant pre-existing cardiovascular diseases. A clinical benefit of liposomal forms of anthracycline is still debatable. METHODS Polish registry… read more here.
Keywords: chemotherapy; premature; heart failure; lymphoma patients ... See more keywords